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Abstract
The purposes of this study were 1) to examine the performance of a new multimarker regression
approach for model-free linkage analysis in comparison to a conventional multipoint approach, and
2) to determine the whether a conditioning strategy would improve the performance of the
conventional multipoint method when applied to data from two interacting loci. Linkage analysis of
the Kofendrerd Personality Disorder phenotype to chromosomes 1 and 3 was performed in three
populations for all 100 replicates of the Genetic Analysis Workshop 14 simulated data. Three
approaches were used: a conventional multipoint analysis using the Zlr statistic as calculated in the
program ALLEGRO; a conditioning approach in which the per-family contribution on one
chromosome was weighted according to evidence for linkage on the other chromosome; and a
novel multimarker regression approach. The multipoint and multimarker approaches were
generally successful in localizing known susceptibility loci on chromosomes 1 and 3, and were found
to give broadly similar results. No advantage was found with the per-family conditioning approach.
The effect on power and type I error of different choices of weighting scheme (to account for
different numbers of affected siblings) in the multimarker approach was examined.
Methods
Linkage analysis of the Kofendrerd Personality Disorder
(KPD) phenotype to chromosomes 1 and 3 was per-
formed in the Danacaa, Karangar, and Aipoto popula-
tions, with knowledge of the "answers". An important aim
of our investigation was to compare the results from an
affected sib-pair (ASP) multimarker approach with those
from a conventional multipoint approach, and these pop-
ulations were chosen because of their ascertainment via
nuclear families rather than via multi-generational pedi-
grees. Multipoint linkage analysis was performed using
the allele-sharing Zlr statistic [1] as calculated in the pro-
gram ALLEGRO [2] under an exponential model. Since it
was known from the "answers" that the disease loci on
chromosomes 1 and 3 interact in an epistatic manner, we
also performed a weighted conditional analysis in which
the per-family contribution to the Zlr on one chromo-
some was weighted according to evidence for linkage on
the other chromosome, as previously suggested [3].
The results from the multipoint approach were compared
with those from a multimarker regression approach that
models the observed identity-by-descent (IBD) states for
ASPs at a series of genetic markers in terms of the IBD state
at a presumed disease locus in the region. The expected
IBD state at the disease locus, and hence the expected IBD
state at the marker loci, are considered parameters to be
estimated in the regression procedure. For a given marker
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and parent type (mother or father), the expected IBD state
can be written as pM = x1 + pDx2, where pM and pD corre-
spond to the probability of sharing an allele IBD at the
marker and disease locus, respectively, and the x variables
correspond to conditional probabilities of marker IBD
state given disease locus IBD state: x1 = P(M|d) and x2 =
P(M|D) - P(M|d). Here M and m denote the events that
the observed marker IBD state is 1 and 0, and D and d the
events that the disease IBD state is 1 and 0, respectively.
These may be written P(M|D) = θ2+(1 - θ)2 and P(M|d) =
1 - P(m|d) = 1 - P(M|D). Thus, the expected IBD states at
each of the markers are modelled in terms of pD, the
expected IBD state at the disease locus (which will be esti-
mated as a regression coefficient), and x variables that are
functions of the recombination fractions θ between the
markers and disease locus. The IBD states for mothers and
fathers are modelled separately (assuming independ-
ence), which allows the possibility of using different val-
ues of θ for the two types of parent, i.e., incorporating sex-
specific recombination fractions if desired.
The model specifying the expected IBD states is fitted to
the observed marker IBD states via a generalized estimat-
ing equation (GEE) approach. Because the IBD state is
considered for each parent separately, the observed IBD
events are Bernoulli random variables with known func-
tional relationship between the mean and variance, and
correlation between IBD states (at different markers for a
given parent type) that depends on pD and the known
recombination fractions between the markers. The data
may be analyzed via standard GEE software that allows
specification of the correlation structure (specified under
the null hypothesis that pD = 0.5). At a given putative dis-
ease locus location, this procedure provides an estimate
 of pD together with its estimated standard error SE
( ) that may be used to produce a z-score (  - 0.5)/SE
( ) that is normally distributed under the null hypoth-
esis that pD = 0.5. The whole procedure is repeated with
the disease locus allowed to take a variety of putative posi-
tions along the marker map, and the position where the z-
score is most significant is taken as the estimate of the dis-
ease locus location. An example of the fitted regression
line, using the disease locus location that gives maximal
evidence against the null hypothesis, is shown in Figure 1
for chromosomes 1 and 3 of the Danacaa data, replicate
100.
The multimarker approach is both conceptually and ana-
lytically very similar to a previously proposed GEE
approach [4]. The multimarker approach differs from the
previously proposed method mainly with regard to the
test statistic, which is calculated at a variety of increments
ˆ pD
ˆ pD ˆ pD
ˆ pD
Example of multimarker approach for Danacaa population, replicate 100 Figure 1
Example of multimarker approach for Danacaa population, replicate 100. Results are shown for the fitted regression line that 
maximizes the test of pD = 0.5 across each chromosome.
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(putative positions of the disease locus) across the region,
in an approach akin to standard multipoint analysis. The
multimarker approach also differs from the previously
proposed approach by considering the contribution of
each parent separately, which could potentially allow the
use of different marker maps in males and females
(although sex-specific maps were not provided for these
data). From Figure 1, it is clear that the greatest contribu-
tion to the test statistic at a given disease locus location
will come from the observed IBD states at the two flanking
markers. The speed of the multimarker procedure can
therefore be considerably increased by using data only
from the two flanking markers, in an interval mapping
type approach, when testing a putative disease location.
For each parent, we used data from the two flanking mark-
ers (when informative) or the closest informative flanking
markers otherwise. In practice, this appeared to make very
little difference to the multimarker results (data not
shown) and so results presented here will all assume the
flanking marker approximation.
An issue not investigated in the previously proposed
approach [4] was the choice of different possible weight-
ing schemes for ASPs derived from sibships with more
than two affected individuals. Several different weighting
schemes have been proposed to adjust for the non-inde-
pendence of such affected pairs, but the optimal scheme
will depend both on the analysis method used and on
whether the goal is merely to maintain type I error or also
increase power [5]. With regard to power, the optimal
weighting scheme may depend on the unknown underly-
ing genetic model [5]. We investigated the performance of
four different weighting schemes for the multimarker
approach. The schemes investigated were 1) the Hodge
scheme [6], in which the contribution of each ASP from a
sibship with a affected individuals is scaled by a factor of
Comparison of multipoint results (shown with solid lines) and multimarker results (shown with dashed lines) for replicate 100 Figure 2
Comparison of multipoint results (shown with solid lines) and multimarker results (shown with dashed lines) for replicate 100.
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(4/3)(2a-3+0.5a-1)/[a(a-1)]; 2) the Suarez and Hodge
scheme [7], in which each ASP's contribution is scaled by
a factor of 2/a; 3) the scheme used by Liang et al. [4], in
which each family contributes equally, achieved by scal-
ing the contribution of each pair by a factor of 2/[a(a-1)];
4) a scheme where each pair contributes equally regard-
less of the number of affected sibs in the family. These
weighting schemes were incorporated into the multima-
rker analysis via use of importance weights in the statisti-
cal analysis package STATA.
Results
Figure 2 shows the results from the multipoint and multi-
marker (with Hodge weights) approaches applied to a sin-
gle replicate, replicate 100. Results are very similar for
both methods. The Danacaa study appears to provide
good evidence for the disease locus on chromosome 1,
but the results on chromosome 3 are less convincing. The
Karangar and Aipotu studies show little evidence of link-
age on chromosome 1 but provide good evidence of link-
age for the disease locus on chromosome 3. The results for
the multipoint analysis of all 100 replicates are shown in
Table 1. The average maximum Zlr on each chromosome
is slightly higher than the average Zlr at the true disease
locus location, as expected, owing to the upward bias
incurred by choosing the maximum on a chromosome.
The Danacaa study generally provides good evidence for
the disease loci on chromosomes 1 (mean Zlr = 4.52, p =
3 ×10-6) and 3 (mean Zlr = 3.92, p = 4 ×10-5). The Kara-
ngar study provides reasonable evidence for the disease
locus on chromosome 3 (mean Zlr = 2.80, p = 0.002) but
little evidence on chromosome 1 (mean Zlr = 1.32, p =
0.09), while the Aipotu study provides good evidence for
the disease locus on chromosome 3 (mean Zlr = 3.20, p =
0.0007) and some evidence for the disease locus on chro-
mosome 1 (mean Zlr = 2.08, p = 0.02). The Zlr scores from
the conditional weighted analyses are lower than those
from the unweighted analysis, indicating no advantage
from using conditioning weights.
The z-score results from the multimarker approach are
given in Table 2, and are found to be broadly comparable
with the multipoint results, particularly when using the
Hodge or Suarez and Hodge weighting schemes. Type I
error is acceptable for all four weighting schemes, as
shown in Table 2 by the analysis of chromosome 4, on
which no disease locus exists. The mean z-score on chro-
mosome 4 is close to 0 with variance close to 1 and
approximate normality (and therefore correct type I error,
data not shown) for all four weighting schemes. The posi-
tions of the maximum Zlr from the multipoint approach
and the maximum z-score from the multimarker
approach are shown in Figure 3. Localization of the dis-
ease loci (at true positions approximately 173 cM on chro-
mosome 1 and 314 cM on chromosome 3) is generally
good for both methods, although there is some sugges-
tion that the localization on chromosome 1 in the Dan-
acaa population is slightly more precise under the
multipoint approach.
Discussion
Overall, the multimarker and multipoint approaches
appear to provide quite similar results, particularly when
using the Hodge or Suarez and Hodge weighting schemes.
Slightly greater power for the multimarker approach is
obtained using the 'Equal pairs' weighting scheme, which
is consistent with the results of Sham et al. [5]. The gener-
ally stronger results from the Danacaa study in compari-
son to the Karangar and Aipotu studies are perhaps not
surprising, given that the ascertainment of the Danacaa
Table 1: Average Zlr z-score (over 100 replicates) using multipoint and weighted conditional analysis
Danacaa Karangar Aipotu
Maximum zz   at true location Maximum zz   at true location Maximum zz   at true location
Chr Conditioning weightsA Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 Unweighted 4.83 0.89 4.52 0.96 2.35 0.72 1.32 1.14 2.70 0.74 2.08 0.97
Weights 0–1 -b - 3.30 1.07 - - 0.73 1.12 - - 1.49 0.96
Weights 1–0 - - 2.09 1.18 - - 0.80 1.06 - - 1.18 0.95
Weights NPL - - 2.95 1.00 - - 0.67 1.09 - - 1.30 1.05
Max weights - - 3.55 0.90 - - 1.39 0.89 - - 1.99 0.74
3 Unweighted 3.99 1.05 3.92 1.11 3.06 0.81 2.80 1.03 3.36 0.97 3.20 1.06
Weights 0–1 - - 3.13 1.10 - - 1.91 1.07 - - 2.31 1.04
Weights 1–0 - - 2.19 1.12 - - 2.02 0.94 - - 2.09 1.19
Weights NPL - - 2.74 1.19 - - 1.51 1.06 - - 1.94 1.01
Max weights - - 3.43 1.02 - - 2.56 0.79 - - 2.91 0.93
aWeights 0–1, 1–0 and NPL are described by Cox et al. [3], where Weights NPL is called weightPROP. Max weights corresponds to the maximum 
Zlr under the 0–1, 1–0, and NPL weighting schemes.
b-, results not calculated.BMC Genetics 2005, 6:S40
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families is via phenotype 1, which is influenced solely by
the disease loci on chromosomes 1 and 3.
The Zlr scores from the conditional weighted analyses are
lower than those from the unweighted analysis, indicating
no improvement in power from using conditioning
weights, and no power to detect an interaction. The exact
form of the proposed interaction is not specified in the
"answers" and could potentially correspond to a number
of different underlying scenarios [8]. Only those scenarios
that result in departure from a multiplicative penetrance
model might in fact be expected to be detectable using the
approach described here.
Conclusion
The multipoint and multimarker approaches were gener-
ally successful in localizing known susceptibility loci on
chromosomes 1 and 3, and were found to give broadly
similar results. No advantage was found with a per-family
conditioning approach. For the multimarker approach,
greatest power and acceptable type I error was seen with
the 'Equal pairs' weighting scheme.
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Table 2: Average z-score (over 100 replicates) using multimarker analysis with various sibship weighting schemes
Danacaa Karangar Aipotu
Maximum zz   at true location Maximum zz   at true location Maximum zz   at true location
Chr Weighting Scheme Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 Hodge 4.99 0.83 4.67 0.89 2.33 0.75 1.35 1.16 2.74 0.78 2.15 1.02
Suarez & Hodge 4.93 0.82 4.62 0.88 2.32 0.74 1.32 1.15 2.72 0.77 2.11 1.01
Equal families 4.42 0.74 4.1 0.83 2.24 0.65 1.12 1.08 2.54 0.72 1.82 1.00
Equal pairs 5.16 0.92 4.85 0.96 2.41 0.85 1.46 1.24 2.83 0.84 2.24 1.06
3 Hodge 4.04 1.04 3.95 1.11 3.03 0.76 2.78 0.99 3.39 0.97 3.23 1.05
Suarez & Hodge 4.02 1.03 3.94 1.10 3.02 0.76 2.76 0.99 3.36 0.97 3.2 1.05
Equal families 3.77 0.96 3.68 1.04 2.86 0.73 2.56 0.98 3.08 0.94 2.86 1.04
Equal pairs 4.03 1.07 3.94 1.16 3.05 0.79 2.78 1.01 3.46 0.98 3.28 1.09
4H o d g e - a - 0.01 0.98 - - 0.03 1.04 - - 0.05 1.01
Suarez & Hodge - - 0.00 0.98 - - 0.03 1.03 - - 0.05 1.01
Equal families - - -0.02 1.00 - - 0.04 1.03 - - 0.07 1.02
Equal pairs - - 0.03 0.98 - - 0.02 1.04 - - 0.03 1.01
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Histograms showing location of maximum over 100 replicates for multipoint and multimarker methods Figure 3
Histograms showing location of maximum over 100 replicates for multipoint and multimarker methods.
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